Abstract
Summary
Hematology is defined as the diagnostic classification of cells present in the blood and resulting identification of diseases of the blood-forming organs and diseases of the blood. It includes the calculation of WBC, RBC, and platelets.
LPI (LP Information)' newest research report, the “Hematology Diagnostics Industry Forecast” looks at past sales and reviews total world Hematology Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Hematology Diagnostics sales for 2023 through 2029. With Hematology Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hematology Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Hematology Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hematology Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hematology Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hematology Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hematology Diagnostics.
The global Hematology Diagnostics market size is projected to grow from US$ 2075.1 million in 2022 to US$ 2687.7 million in 2029; it is expected to grow at a CAGR of 2687.7 from 2023 to 2029.
Hematology testing devices have come a long way from disease detection and monitoring to counting and characterizing blood cells. The concept of automation has extended to detect small cell populations in order to diagnose rare blood conditions, which requires less labor, rapid result, and easy-to-use analyzers. Current technologies include automation of hematology analyzer, electrical impedance, flow cytometry, and fluorescent flow.
This report presents a comprehensive overview, market shares, and growth opportunities of Hematology Diagnostics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Hematology Instruments
Hematology Consumables
Segmentation by application
Diagnostic Laboratories
Hospitals & Clinics
Academic Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Sysmex Corporation
F. Hoffmann-La Roche
Beckman Coulter
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hematology Diagnostics market?
What factors are driving Hematology Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hematology Diagnostics market opportunities vary by end market size?
How does Hematology Diagnostics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Hematology Diagnostics Industry Forecast” looks at past sales and reviews total world Hematology Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Hematology Diagnostics sales for 2023 through 2029. With Hematology Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hematology Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Hematology Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hematology Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hematology Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hematology Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hematology Diagnostics.
The global Hematology Diagnostics market size is projected to grow from US$ 2075.1 million in 2022 to US$ 2687.7 million in 2029; it is expected to grow at a CAGR of 2687.7 from 2023 to 2029.
Hematology testing devices have come a long way from disease detection and monitoring to counting and characterizing blood cells. The concept of automation has extended to detect small cell populations in order to diagnose rare blood conditions, which requires less labor, rapid result, and easy-to-use analyzers. Current technologies include automation of hematology analyzer, electrical impedance, flow cytometry, and fluorescent flow.
This report presents a comprehensive overview, market shares, and growth opportunities of Hematology Diagnostics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Hematology Instruments
Hematology Consumables
Segmentation by application
Diagnostic Laboratories
Hospitals & Clinics
Academic Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Sysmex Corporation
F. Hoffmann-La Roche
Beckman Coulter
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hematology Diagnostics market?
What factors are driving Hematology Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hematology Diagnostics market opportunities vary by end market size?
How does Hematology Diagnostics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hematology Diagnostics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hematology Diagnostics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hematology Diagnostics by Country/Region, 2018, 2022 & 2029
2.2 Hematology Diagnostics Segment by Type
2.2.1 Hematology Instruments
2.2.2 Hematology Consumables
2.3 Hematology Diagnostics Sales by Type
2.3.1 Global Hematology Diagnostics Sales Market Share by Type (2018-2023)
2.3.2 Global Hematology Diagnostics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hematology Diagnostics Sale Price by Type (2018-2023)
2.4 Hematology Diagnostics Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals & Clinics
2.4.3 Academic Institutes
2.4.4 Others
2.5 Hematology Diagnostics Sales by Application
2.5.1 Global Hematology Diagnostics Sale Market Share by Application (2018-2023)
2.5.2 Global Hematology Diagnostics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hematology Diagnostics Sale Price by Application (2018-2023)
3 Global Hematology Diagnostics by Company
3.1 Global Hematology Diagnostics Breakdown Data by Company
3.1.1 Global Hematology Diagnostics Annual Sales by Company (2018-2023)
3.1.2 Global Hematology Diagnostics Sales Market Share by Company (2018-2023)
3.2 Global Hematology Diagnostics Annual Revenue by Company (2018-2023)
3.2.1 Global Hematology Diagnostics Revenue by Company (2018-2023)
3.2.2 Global Hematology Diagnostics Revenue Market Share by Company (2018-2023)
3.3 Global Hematology Diagnostics Sale Price by Company
3.4 Key Manufacturers Hematology Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hematology Diagnostics Product Location Distribution
3.4.2 Players Hematology Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hematology Diagnostics by Geographic Region
4.1 World Historic Hematology Diagnostics Market Size by Geographic Region (2018-2023)
4.1.1 Global Hematology Diagnostics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hematology Diagnostics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hematology Diagnostics Market Size by Country/Region (2018-2023)
4.2.1 Global Hematology Diagnostics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hematology Diagnostics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hematology Diagnostics Sales Growth
4.4 APAC Hematology Diagnostics Sales Growth
4.5 Europe Hematology Diagnostics Sales Growth
4.6 Middle East & Africa Hematology Diagnostics Sales Growth
5 Americas
5.1 Americas Hematology Diagnostics Sales by Country
5.1.1 Americas Hematology Diagnostics Sales by Country (2018-2023)
5.1.2 Americas Hematology Diagnostics Revenue by Country (2018-2023)
5.2 Americas Hematology Diagnostics Sales by Type
5.3 Americas Hematology Diagnostics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hematology Diagnostics Sales by Region
6.1.1 APAC Hematology Diagnostics Sales by Region (2018-2023)
6.1.2 APAC Hematology Diagnostics Revenue by Region (2018-2023)
6.2 APAC Hematology Diagnostics Sales by Type
6.3 APAC Hematology Diagnostics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hematology Diagnostics by Country
7.1.1 Europe Hematology Diagnostics Sales by Country (2018-2023)
7.1.2 Europe Hematology Diagnostics Revenue by Country (2018-2023)
7.2 Europe Hematology Diagnostics Sales by Type
7.3 Europe Hematology Diagnostics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hematology Diagnostics by Country
8.1.1 Middle East & Africa Hematology Diagnostics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hematology Diagnostics Revenue by Country (2018-2023)
8.2 Middle East & Africa Hematology Diagnostics Sales by Type
8.3 Middle East & Africa Hematology Diagnostics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hematology Diagnostics
10.3 Manufacturing Process Analysis of Hematology Diagnostics
10.4 Industry Chain Structure of Hematology Diagnostics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hematology Diagnostics Distributors
11.3 Hematology Diagnostics Customer
12 World Forecast Review for Hematology Diagnostics by Geographic Region
12.1 Global Hematology Diagnostics Market Size Forecast by Region
12.1.1 Global Hematology Diagnostics Forecast by Region (2024-2029)
12.1.2 Global Hematology Diagnostics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hematology Diagnostics Forecast by Type
12.7 Global Hematology Diagnostics Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Hematology Diagnostics Product Portfolios and Specifications
13.1.3 Abbott Laboratories Hematology Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Sysmex Corporation
13.2.1 Sysmex Corporation Company Information
13.2.2 Sysmex Corporation Hematology Diagnostics Product Portfolios and Specifications
13.2.3 Sysmex Corporation Hematology Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sysmex Corporation Main Business Overview
13.2.5 Sysmex Corporation Latest Developments
13.3 F. Hoffmann-La Roche
13.3.1 F. Hoffmann-La Roche Company Information
13.3.2 F. Hoffmann-La Roche Hematology Diagnostics Product Portfolios and Specifications
13.3.3 F. Hoffmann-La Roche Hematology Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 F. Hoffmann-La Roche Main Business Overview
13.3.5 F. Hoffmann-La Roche Latest Developments
13.4 Beckman Coulter
13.4.1 Beckman Coulter Company Information
13.4.2 Beckman Coulter Hematology Diagnostics Product Portfolios and Specifications
13.4.3 Beckman Coulter Hematology Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beckman Coulter Main Business Overview
13.4.5 Beckman Coulter Latest Developments
14 Research Findings and Conclusion